Why clinical oncologists should talk about the price of cancer drugs.
Co-author of the revised and expanded second edition of The Hastings Center Guidelines for Decisions on Life-Sustaining Treatment and Care Near the End of Life (Oxford, 2013), and author of After Harm: Medical Error and the Ethics of Forgiveness (Johns Hopkins, 2005), and co-directs the Undocumented Patients project on access to health care for undocumented immigrants.
Nancy
N
Berlinger
D000970:Antineoplastic Agents / Q000191:economics* / Q000627:therapeutic use*; D003362:Cost-Benefit Analysis; D018572:Disease-Free Survival; D016527:Drug Costs; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000191:economics*; D026712:Value of Life
D000970:Antineoplastic Agents